Skip to main content
Rainmed Medical Limited logo

Rainmed Medical Limited — Investor Relations & Filings

Ticker · 2297 HKEX Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2025-05-26 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 2297

About Rainmed Medical Limited

http://www.rainmed.com

Rainmed Medical Group, founded in 2014, is a high-tech enterprise specializing in the research, development, manufacturing, and commercialization of advanced medical instruments for vascular interventional procedures. The company is committed to becoming a global leader in vascular interventional surgical robotics. Its core product portfolio centers on robotic digital functional diagnosis modules, including the coronary angiography-derived fractional flow reserve (caFFR) system and the coronary angiography-derived microvascular resistance index (caIMR) system. These diagnostic tools form the foundation for the development of the FlashBot Vascular Interventional Surgical Robot, which aims to provide a one-stop procedural solution for precision medicine in cardiovascular care. Rainmed maintains a global R&D network, collaborates with top medical centers, and focuses on advancing its patented technologies.

Recent filings

Filing Released Lang Actions
SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE AND VOLUNTARY LOCK-UP UNDERTAKINGS
Share Issue/Capital Change Classification · 1% confidence The document is an announcement published on the Hong Kong Stock Exchange regarding the Subscription Agreement for the issuance of 233,559,800 new shares under a general mandate, including terms, conditions precedent, pricing, shareholding structure effects, and lock-up undertakings. This clearly describes a new share issue and change in capital structure, matching the definition for Share Issue/Capital Change (Code: SHA).
2025-05-26 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025
Regulatory Filings Classification · 1% confidence The document is a Monthly Return for an equity issuer under HKEX Listing Rules, detailing movements in authorised/registered share capital, issued shares, share options, and confirmations. It is a periodic regulatory submission rather than an earnings announcement, annual report, share issue notice, or AGM material. This type of compliance filing does not fit the specific categories (10-K, ER, SHA, etc.) and therefore falls under the general “Regulatory Filings” fallback category (RNS).
2025-05-02 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 27, 2025
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a "Form of Proxy" for use at the Annual General Meeting, allowing shareholders to appoint a proxy and vote on resolutions. This type of document is part of the proxy solicitation materials sent to shareholders to inform them about the meeting and solicit their votes. It is not the AGM presentation itself, nor the notice of voting results, nor a financial report. Therefore, it matches the Proxy Solicitation & Information Statement category (PSI).
2025-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of the upcoming Annual General Meeting, listing resolutions to be voted on, proxy appointment instructions, record dates, and other meeting logistics. It is not the AGM materials themselves nor an annual/quarterly report; instead it serves to solicit proxies and inform shareholders for voting. Therefore, it best fits the Proxy Solicitation & Information Statement category (PSI).
2025-04-29 English
(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; (2) RE-ELECTION OF RETIRING DIRECTORS&#x3b; (3) RE-APPOINTMENT OF AUDITOR&#x3b; AND (4) NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a pre-meeting shareholder circular (“THIS CIRCULAR IS IMPORTANT…”) issued by Rainmed Medical Limited, containing proposals for general mandates to issue and repurchase shares, re-election of directors, re-appointment of auditor, plus the formal notice of the Annual General Meeting and enclosed proxy form. Such materials are sent to shareholders to provide information and solicit their votes at the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2025-04-29 English
ANNUAL REPORT 2024
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL REPORT 2024' and contains comprehensive sections including company profile, financial highlights, management discussion and analysis, directors' report, corporate governance report, independent auditor's report, and full consolidated financial statements. It covers the fiscal year ended December 31, 2024, and provides detailed operational and financial performance data, fitting the definition of an Annual Report (10-K). FY 2024
2025-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.